Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor
- 1 August 1992
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 340 (8814) , 307
- https://doi.org/10.1016/0140-6736(92)92396-w
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes.Journal of Clinical Investigation, 1991
- Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assayHepatology, 1991
- Primary structure of rat hepatocyte growth factor and induction of its mRNA during liver regeneration following hepatic injuryEuropean Journal of Biochemistry, 1990
- Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failureHepatology, 1989
- Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure.Journal of Clinical Investigation, 1988
- Multivariate analysis of prognostic factors in fulminant hepatitis BHepatology, 1986
- Relation of Alpha-Fetoprotein in Acute Hepatitis to Severity and PrognosisAnnals of Internal Medicine, 1974